These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14989201)

  • 1. Is autovaccination dead?
    Hirschel B
    Res Initiat Treat Action; 2003; 9(2):16. PubMed ID: 14989201
    [No Abstract]   [Full Text] [Related]  

  • 2. A look at HIV immune research. Interview by Alan Huff.
    Landay A
    Res Initiat Treat Action; 2000 Sep; 6(3):30-3. PubMed ID: 11708165
    [No Abstract]   [Full Text] [Related]  

  • 3. Data released on immune therapy.
    AIDS Patient Care STDS; 2005 Oct; 19(10):699. PubMed ID: 16232055
    [No Abstract]   [Full Text] [Related]  

  • 4. Trial suggests vaccines could aid HIV therapy.
    Check E
    Nature; 2003 Apr; 422(6933):650. PubMed ID: 12700722
    [No Abstract]   [Full Text] [Related]  

  • 5. New strategies to combat HIV: augmenting antiviral immunity.
    Smith KA; Boyle BA
    AIDS Read; 2003 Aug; 13(8):365-9, 382. PubMed ID: 14524321
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV vaccination].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():68-9. PubMed ID: 19031568
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
    Boström AC; Hejdeman B; Matsuda R; Fredriksson M; Fredriksson EL; Bratt G; Sandström E; Wahren B
    Vaccine; 2004 Apr; 22(13-14):1683-91. PubMed ID: 15068851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell vaccination against anti-CD4 autoimmunity in HIV-1 infected patients.
    Abulafia-Lapid R; Bentwich Z; Keren-Zur Y; Cohen IR; Atlan H
    J Clin Virol; 2004 Dec; 31 Suppl 1():S48-54. PubMed ID: 15567094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies toward restoration of immunity to HIV.
    Autran B
    AIDS; 2002 Jul; 16(10):4-6. PubMed ID: 12146461
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccines. Study finds Remune reduces risk of virologic failure.
    TreatmentUpdate; 2004 Oct; 16(6):3-4. PubMed ID: 17225281
    [No Abstract]   [Full Text] [Related]  

  • 11. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C; Lee S; Wong Kh; Cheng L; Lam M
    HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization.
    Kran AM; Sommerfelt MA; Sørensen B; Nyhus J; Baksaas I; Bruun JN; Kvale D
    Vaccine; 2005 Jul; 23(31):4011-5. PubMed ID: 15963359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients.
    Lévy Y; Gahéry-Ségard H; Durier C; Lascaux AS; Goujard C; Meiffrédy V; Rouzioux C; El Habib R; Beumont-Mauviel M; Guillet JG; Delfraissy JF; Aboulker JP;
    AIDS; 2005 Feb; 19(3):279-86. PubMed ID: 15718838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eager Thailand takes on questionable therapies.
    Birmingham K
    Nat Med; 2002 Aug; 8(8):767-8. PubMed ID: 12152015
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users.
    Tarwater PM; Gallant JE; Mellors JW; Gore ME; Phair JP; Detels R; Margolick JB; Muñoz A
    AIDS; 2004 Dec; 18(18):2419-23. PubMed ID: 15622318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The paradox of incomplete CD4+ cell count restoration despite successful antiretroviral treatment and the need to start highly active antiretroviral therapy early.
    Julg B; Walker BD
    Clin Infect Dis; 2009 Mar; 48(6):795-7. PubMed ID: 19196173
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNE) therapy in Thailand.
    Chantratita W; Sukeepaisarncharoen W; Chandeying V; Kulpradist S; Israngkura Na Ayudhtaya B; Rugpao S; Sirawaraporn W; Boonshuyar C; Churdboonchart V
    HIV Med; 2004 Sep; 5(5):317-25. PubMed ID: 15369506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy.
    Petrovas C; Mueller YM; Katsikis PD
    Cell Death Differ; 2005 Aug; 12 Suppl 1():859-70. PubMed ID: 15818412
    [No Abstract]   [Full Text] [Related]  

  • 20. 30 years after HIV identification: where to from here?
    Stover J
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):947-9. PubMed ID: 22029511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.